The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

In a clinical trial of more than 3,000 adults with obesity, individuals taking the highest dose of Foundayo and who stayed on ...

By Leah Douglas and Christy Santhosh April 1 (Reuters) - The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, ...

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...

A doctor discusses the most common issues and questions Americans may have with the FDA's approval of the new oral obesity ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

According to Eli Lilly, based on clinical studies, the side effects of the Foundayo pill include nausea, constipation, ...

The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight ...

A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval ...

"Weight loss" and "fat loss" are terms often used interchangeably, but it's useful to understand the difference. An expert ...

Losing weight can definitely help lower blood pressure. Research shows that losing about 11 pounds (5 kilograms) reduces ...